Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
McKesson
Baxter
Express Scripts
Medtronic
Mallinckrodt

Last Updated: November 20, 2019

DrugPatentWatch Database Preview

Litigation Details for Shire LLC v. Watson Laboratories Inc (D.N.J. 2012)

See Plans and Pricing

« Back to Dashboard

Shire LLC v. Watson Laboratories Inc (D.N.J. 2012)

Docket   Start Trial Date Filed 2012-01-05
Court District Court, D. New Jersey Date Terminated 2014-04-09
Cause 35:271 Patent Infringement Assigned To Stanley R. Chesler
Jury Demand None Referred To Cathy L. Waldor
Parties JOHNSON MATTHEY INC.; JOHNSON MATTHEY PHARMACEUTICAL MATERIALS; SHIRE DEVELOPMENT INC; SHIRE DEVELOPMENT LLC; SHIRE LLC; WATSON LABORATORIES INC
Patents 7,105,486; 7,223,735; 7,655,630; 7,659,253; 7,659,254; 7,662,787; 7,662,788; 7,671,030; 7,671,031; 7,674,774; 7,678,770; 7,678,771; 7,687,466; 7,687,467; 7,700,561; 7,713,936; 7,718,619; 7,723,305
Attorneys CHRISTOPHER PAUL MIDURA; ERICA SUSAN HELMS; GREGORY ROBERT HAWORTH; KAREN A. CONFOY; LISA H. WANG; MICHAEL R. GRIFFINGER
Firms Fox Rothschild LLP, Pc; Goldberg Segalla, L.L.P.; Law Office of Lisa H. Wang
Link to Docket External link to docket
Small Molecule Drugs cited in Shire LLC v. Watson Laboratories Inc
The small molecule drug covered by the patents cited in this case is   Start Trial .

Details for Shire LLC v. Watson Laboratories Inc (D.N.J. 2012)

Date Filed Document No. Description Snippet Link To Document
2011-07-06 1 Complaint States Patent No. 7,105,486 (“the ’486 patent”) (attached as Exhibit’ A hereto); United States Patent No.…’630 patent, the ’253 patent, the ’254 patent, the ’787 patent, the ’030 patent, the ’031 patent, the …’774 patent, the ’770 patent, the ’771 patent, the ’466 patent, the ’467 patent, the ’6.19 patent, and…’630 patent, the ’253 patent, the ’254 patent, the ’787 patent, the ’030 patent, the ’031 patent, the …’774 patent, the ’770 patent, the ’771 patent, the ’466 patent, the ’467 patent, the ’619 patent,v and External link to document
2013-08-08 161 Opinion action, eighteen patents are at issue: U.S. Patent No. 7,105,486 (the “’486 patent”); … “’788 patent”); U.S. Patent No. 7,671,030 (the “’030 patent”); U.S. Patent No. 7,… “’031 patent”); U.S. Patent No. 7,674,774 (the “’774 patent”); U.S. Patent No. 7,… “’770 patent”); U.S. Patent No. 7,678,771 (the “’771 patent”); U.S. Patent No. 7,… “’466 patent”); U.S. Patent No. 7,687,467 (the “’467 patent”); U.S. Patent No. 7, External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Merck
McKinsey
Express Scripts
Harvard Business School
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.